Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Alcon Inc. before investing.

In this article, we go over a few key elements for understanding Alcon Inc.’s stock price such as:

• Alcon Inc.’s current stock price and volume
• Why Alcon Inc.’s stock price changed recently
• Upgrades and downgrades for ALC from analysts
• ALC’s stock price momentum as measured by its relative strength

About Alcon Inc. (ALC)

Before we jump into Alcon Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Want to learn more about Alcon Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Alcon Inc..

Alcon Inc.’s Stock Price as of Market Close

As of September 14, 2026, 4:00 PM, CST, Alcon Inc.’s stock price was $67.740.

Alcon Inc. is up 2.59% from its previous closing price of $66.030.

During the last market session, Alcon Inc.’s stock traded between $66.640 and $67.790. Currently, there are approximately 486.70 million shares outstanding for Alcon Inc..

Alcon Inc.’s price-earnings (P/E) ratio is currently at 51.6, which is high compared to the Health Care Equipment & Supplies industry median of 25.4. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Alcon Inc. Stock Price History

Alcon Inc.’s (ALC) price is currently down 6% so far this month.

During the month of September, Alcon Inc.’s stock price has reached a high of $73.520 and a low of $65.940.

Over the last year, Alcon Inc. has hit prices as high as $87.640 and as low as $61.835. Year to date, Alcon Inc.’s stock is down 14.05%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Alcon Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 14, 2026, there were analysts who downgraded Alcon Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Alcon Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Alcon Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Alcon Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Alcon Inc. (ALC) by visiting AAII Stock Evaluator.

Relative Price Strength of Alcon Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 14, 2026, Alcon Inc. has a weighted four-quarter relative price strength of -4.86%, which translates to a Momentum Score of 36 and is considered to be Weak.

Want to learn more about how Alcon Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Alcon Inc. Stock Price: Bottom Line

As of September 14, 2026, Alcon Inc.’s stock price is $67.740, which is up 2.59% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Alcon Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.